Report Code : CVMI2501124 | Published Date : March 3, 2025

The Global Infectious Disease Diagnostics Market is experiencing unprecedented growth driven by emerging pathogens, increasing antimicrobial resistance, and technological advancements in diagnostic techniques. Valued at USD 28.4 billion in 2023, the market is projected to expand at a CAGR of 7.9%, reaching USD 51.2 billion by 2031.

The COVID-19 pandemic has fundamentally transformed the diagnostics landscape, accelerating the development and adoption of rapid testing platforms. Emerging threats such as antimicrobial-resistant infections and zoonotic diseases are further driving market growth. This report offers detailed segmentation analysis, regional insights, and future projections to assist stakeholders in navigating this evolving market.

2. Market Overview

2.1 Market Definition & Scope

Infectious disease diagnostics encompass technologies and products used to detect pathogens causing diseases in humans. The market includes:

  • Molecular Diagnostics (PCR, NAAT, Sequencing)
  • Immunoassays (ELISA, Rapid Tests)
  • Microbiology Culture Techniques
  • Point-of-Care Testing Devices
  • Next-Generation Sequencing Platforms

2.2 Market Size & Forecast (2023-2031)

  • 2023 Market Size: USD 28.4 Billion
  • 2031 Projected Size: USD 51.2 Billion
  • CAGR: 7.9%
  • Test Volume: 45 billion tests annually (2023) → 68 billion tests (2031)

2.3 Key Market Segments

By Product Type:

  1. Reagents & Kits (XX% share)
    • PCR reagents (XX%)
    • Lateral flow components (XX%)
    • Culture media (XX%)
    • Others (20%)
  2. Instruments (XX%)
    • PCR systems (XX%)
    • Automated immunoassay analyzers (XX%)
    • Mass spectrometers (XX%)
    • Others (XX%)
  3. Software & Services (25%)

By Technology:

  • Molecular Diagnostics (XX%)
  • Immunoassays (XX%)
  • Microbiology (XX%)
  • Other Technologies (10%)

By Disease Type:

  • Respiratory Infections (XX%)
  • HIV/AIDS (XX%)
  • Hepatitis (XX%)
  • STDs (XX%)
  • COVID-19 (8%)
  • Other Diseases (30%)

By End User:

  • Hospitals (XX%)
  • Diagnostic Laboratories (XX%)
  • Research Institutes (XX%)
  • Others (15%)

By Region:

  • North America (XX%)
  • Europe (XX%)
  • Asia-Pacific (28%)
  • Rest of World (XX%)

 

3. Market Dynamics

3.1 Market Drivers

1. Pandemic Preparedness Initiatives

  • USD 12 billion invested globally in diagnostic capacity building post-COVID
  • 75% of countries now have national testing strategies for emerging pathogens

2. Antimicrobial Resistance Crisis

  • 1.27 million deaths annually attributed to AMR
  • 50% increase in demand for antibiotic susceptibility testing since 2020

3. Technological Advancements

  • CRISPR-based diagnostics entering clinical use (30% faster than PCR)
  • AI-powered image analysis reducing culture interpretation time by 40%

4. Point-of-Care Testing Expansion

  • 25% CAGR for rapid diagnostic tests
  • 90% reduction in time-to-result compared to lab-based methods

3.2 Market Challenges

1. Regulatory Hurdles

  • 12-18 month average approval time for new diagnostic tests
  • 30% increase in compliance costs since 2020

2. Reimbursement Limitations

  • 40% of novel tests face coverage challenges
  • 15% lower reimbursement rates in emerging markets

3. Supply Chain Vulnerabilities

  • 20% price increase for PCR reagents due to semiconductor shortages
  • 3-6 month delays for automated analyzer components

3.3 Market Trends

1. Multiplex Testing Adoption

  • 10-plex respiratory panels now standard in ER settings
  • 50% cost reduction per pathogen detected

2. Digital Pathology Integration

  • Whole slide imaging adoption growing at 35% CAGR
  • AI-assisted diagnosis improving accuracy by 25%

3. Home Testing Expansion

  • 120% growth in direct-to-consumer test kits
  • FDA approval of first smartphone-connected STI test

 

4. Competitive Landscape

4.1 Market Share Analysis

Company

Market Share

Key Products

Strategic Focus

Roche Diagnostics

22%

cobas® systems

Molecular diagnostics

Abbott Laboratories

18%

ID NOW™ platform

Point-of-care testing

Thermo Fisher Scientific

15%

TaqPath™ assays

High-throughput testing

bioMérieux

12%

VITEK® systems

Automated microbiology

Danaher Corporation

10%

Cepheid GeneXpert

Rapid molecular testing

4.2 Emerging Players

  • Mammoth Biosciences: CRISPR-based Dx platform (growing at 80% YoY)
  • Visby Medical: Single-use PCR devices
  • Lucira Health: Home molecular testing solutions

4.3 Recent Developments (2024)

  • Roche launched 30-minute multiplex sepsis test
  • Abbott received EUA for AI-driven antibiotic resistance predictor
  • Thermo Fisher acquired sequencing startup for $450M

 

5. Regional Analysis

5.1 North America (XX%)

  • US dominates with 85% of regional market
  • Canada investing in rural POC testing infrastructure

5.2 Europe (XX%)

  • Germany leads in automated microbiology
  • UK prioritizing AMR diagnostics

5.3 Asia-Pacific (28%)

  • China fastest-growing market at 12% CAGR
  • India emerging as tropical disease diagnostics hub

 

6. Future Outlook

6.1 Short-Term Projections (2025)

  • 50% of hospitals to adopt syndromic testing panels
  • FDA clearance expected for first CRISPR-based IVD

6.2 Medium-Term Outlook (2027)

  • 30% of tests to incorporate AI interpretation
  • WGS to become standard for outbreak investigation

6.3 Long-Term Forecast (2031)

  • 70% of routine testing moving to point-of-care
  • Personalized antimicrobial therapy based on rapid diagnostics




Reasons To Buy

Image



Scope

Image

Key Players

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • bioMérieux SA
  • Thermo Fisher Scientific Inc.
  • Becton
  • Dickinson and Company

Global Infectious Disease Diagnostics Market Report

Global Infectious Disease Diagnostics Market Report

  1. 1. Global Infectious Disease Diagnostics Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Infectious Disease Diagnostics Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Infectious Disease Diagnostics Market Research Report - Preface
    1. 2.1 Global Infectious Disease Diagnostics Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Type
      2. 2.1.2 By Pathogen
      3. 2.1.3 By Application
      4. 2.1.4 By Region
    3. Global Infectious Disease Diagnostics Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Type, By Pathogen, By Application, By Country
    3. 3.3. Opportunities – By Type, By Pathogen, By Application, By Country
    4. 3.4. Trends – By Type, By Pathogen, By Application, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Infectious Disease Diagnostics Market Research Report – DROTs Impact Analysis
    4. Global Infectious Disease Diagnostics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Infectious Disease Diagnostics Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Molecular Diagnostics
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Immunoassays
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Microbial Culture
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 5.4 Others
      1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Infectious Disease Diagnostics Market, By Pathogen, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Bacteria
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Viruses
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Fungi
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 6.4 Others
      1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Infectious Disease Diagnostics Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Hospital Laboratories
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Diagnostic Centers
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Point of Care Testing.
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Infectious Disease Diagnostics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 8.5 Middle East & Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 8.6 Global Infectious Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Pathogen, By Application, and Region, 2024 - 2031
    9. North America Infectious Disease Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Molecular Diagnostics
      2. 9.1.2 Immunoassays
      3. 9.1.3 Microbial Culture
      4. 9.1.4 Others
      9.2 By Pathogen Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Bacteria
      2. 9.2.2 Viruses
      3. 9.2.3 Fungi
      4. 9.2.4 Others
      9.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Hospital Laboratories
      2. 9.3.2 Diagnostic Centers
      3. 9.3.3 Point of Care Testing.
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
      9.5 North America Global Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Type, By Pathogen, By Application, and Country, 2024 - 2031
      9.6 Regional Trends Analysis
      9.7 North America Global Infectious Disease Diagnostics Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Infectious Disease Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Molecular Diagnostics
      2. 10.1.2 Immunoassays
      3. 10.1.3 Microbial Culture
      4. 10.1.4 Others
      10.2 By Pathogen Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Bacteria
      2. 10.2.2 Viruses
      3. 10.2.3 Fungi
      4. 10.2.4 Others
      10.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Hospital Laboratories
      2. 10.3.2 Diagnostic Centers
      3. 10.3.3 Point of Care Testing.
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 United Kingdom
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Netherlands
      8. 10.4.8 Poland
      9. 10.4.9 Rest of Europe
      10.5 Europe Global Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Type, By Pathogen, By Application, and Country, 2024 - 2031
      10.6 Regional Trends Analysis
      10.7 Europe Global Infectious Disease Diagnostics Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (United Kingdom)
      3. 10.7.3 Company 3 (United Kingdom)
    11. Asia-Pacific Infectious Disease Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Molecular Diagnostics
      2. 11.1.2 Immunoassays
      3. 11.1.3 Microbial Culture
      4. 11.1.4 Others
      11.2 By Pathogen Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Bacteria
      2. 11.2.2 Viruses
      3. 11.2.3 Fungi
      4. 11.2.4 Others
      11.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Hospital Laboratories
      2. 11.3.2 Diagnostic Centers
      3. 11.3.3 Point of Care Testing.
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 China
      2. 11.4.2 Japan
      3. 11.4.3 India
      4. 11.4.4 South Korea
      5. 11.4.5 Australia & NZ
      6. 11.4.6 ASEAN
      7. 11.4.7 Rest of Asia-Pacific
      11.5 Asia-Pacific Global Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Type, By Pathogen, By Application, and Country, 2024 - 2031
      11.6 Regional Trends Analysis
      11.7 Asia-Pacific Global Infectious Disease Diagnostics Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (China)
      2. 11.7.2 Company 2 (Japan)
      3. 11.7.3 Company 3 (Japan)
    12. Latin America Infectious Disease Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Molecular Diagnostics
      2. 12.1.2 Immunoassays
      3. 12.1.3 Microbial Culture
      4. 12.1.4 Others
      12.2 By Pathogen Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Bacteria
      2. 12.2.2 Viruses
      3. 12.2.3 Fungi
      4. 12.2.4 Others
      12.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Hospital Laboratories
      2. 12.3.2 Diagnostic Centers
      3. 12.3.3 Point of Care Testing.
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Peru
      5. 12.4.5 Colombia
      6. 12.4.6 Rest of Latin America
      12.5 Latin America Global Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Type, By Pathogen, By Application, and Country, 2024 - 2031
      12.6 Regional Trends Analysis
      12.7 Latin America Global Infectious Disease Diagnostics Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East & Africa Infectious Disease Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Molecular Diagnostics
      2. 13.1.2 Immunoassays
      3. 13.1.3 Microbial Culture
      4. 13.1.4 Others
      13.2 By Pathogen Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Bacteria
      2. 13.2.2 Viruses
      3. 13.2.3 Fungi
      4. 13.2.4 Others
      13.3 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Hospital Laboratories
      2. 13.3.2 Diagnostic Centers
      3. 13.3.3 Point of Care Testing.
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Saudi Arabia
      2. 13.4.2 UAE
      3. 13.4.3 South Africa
      4. 13.4.4 Egypt
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
      13.5 Middle East & Africa Global Infectious Disease Diagnostics Market – Opportunity Analysis Index, By Type, By Pathogen, By Application, and Country, 2024 - 2031
      13.6 Regional Trends Analysis
      13.7 Middle East & Africa Global Infectious Disease Diagnostics Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Saudi Arabia)
      2. 13.7.2 Company 2 (UAE)
      3. 13.7.3 Company 3 (UAE)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
      14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 Abbott Laboratories
      2. 14.2.2 F. Hoffmann-La Roche Ltd.
      3. 14.2.3 bioMérieux SA
      4. 14.2.4 Thermo Fisher Scientific Inc.
      5. 14.2.5 Becton
      6. 14.2.6 Dickinson and Company
    15. Data Collection Method and Research Approach
    16. Principal Presumptions and Acronyms